Tegafur-uracil: all 25 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+Status unknownNCT03121313Phase 2
- The Maintenance Treatment of UFT in Advanced Gastric CancerCompletedNCT02903498Phase 2
- A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon CancerStatus unknownNCT02887365Phase 4
- Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical ResectionStatus unknownNCT02836977Not applicable
- Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma RecurrenceCompletedNCT02447679Phase 2
- Sorafenib Plus Tegafur-uracil (UFT) Versus Sorafenib as First Line Systemic Treatment for Patients With Advanced Stage HCC, Unresectable & Not Eligible for Local Ablation and/or TACETerminatedNCT01539018Phase 2
- Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast CancerTerminatedNCT01262274Phase 2
- Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted TherapyCompletedNCT01225744Phase 2
- UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung CancerCompletedNCT01037998Phase 2
- Thalidomide and Tegafur/Uracil(UFUR) in the Treatment of Advanced Colorectal CancerStatus unknownNCT00890188Phase 2
- Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell CarcinomaStatus unknownNCT00855881Phase 2
- Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell CarcinomaStatus unknownNCT00625352Phase 2
- UFUR Plus Thalidomide for Advanced Hepatocellular CarcinomaCompletedNCT00519688Phase 2
- Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)CompletedNCT00464919Phase 2
- A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)Status unknownNCT00384800Phase 2
- S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck CancerStatus unknownNCT00336947Phase 3
- Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal AdenocarcinomaTerminatedNCT00207831Phase 3
- A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)CompletedNCT00190515Phase 3
- Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric CancerCompletedNCT00154778Phase 2
- A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)CompletedNCT00152243Phase 3
- A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)CompletedNCT00152230Phase 3
- A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)CompletedNCT00152191Phase 3
- The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)CompletedNCT00152178Phase 3
- Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung CancerStatus unknownNCT00139971Phase 3
- A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal CancerStatus unknownNCT00037089Phase 2